LEADER 02143nam  2200589Ia 450 
001 9910778666203321
005 20230313210327.0
010   $a0-309-17526-7
010   $a1-280-21070-2
010   $a9786610210701
010   $a0-309-58956-8
010   $a0-585-02111-2
035   $a(CKB)110986584751866
035   $a(OCoLC)42328820
035   $a(CaPaEBR)ebrary10055380
035   $a(SSID)ssj0000275548
035   $a(PQKBManifestationID)11234733
035   $a(PQKBTitleCode)TC0000275548
035   $a(PQKBWorkID)10222620
035   $a(PQKB)10334168
035   $a(MiAaPQ)EBC3376293
035   $a(Au-PeEL)EBL3376293
035   $a(CaPaEBR)ebr10055380
035   $a(OCoLC)923262658
035   $a(EXLCZ)99110986584751866
100   $a19960815d1996      ua             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aXenotransplantation $escience, ethics, and public policy /$fCommittee on Xenograft Transplantation: Ethical Issues and Public Policy, Division of Health Sciences Policy, Division of Health Care Services, Institute of Medicine
210  1$aWashington, D.C. :$cNational Academy Press,$d1996.
215   $a1 online resource (viii, 126 pages) $cillustrations, charts
300   $aBibliographic Level Mode of Issuance: Monograph
311 0 $a0-309-05549-0 
320   $aIncludes bibliographical references.
327   $aSetting the stage Assessing the science base Infectious disease risk to public health posed by xenografting Ethics and public policy Conclusions and recommendations
606   $aBioethics$vCongresses
606   $aXenografts$xGovernment policy$zUnited States$vCongresses
606   $aXenografts$xMoral and ethical aspects$vCongresses
615  0$aBioethics
615  0$aXenografts$xGovernment policy
615  0$aXenografts$xMoral and ethical aspects
676   $a174/.25
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910778666203321
996   $aXenotransplantation$91973610
997   $aUNINA